Onconetix, Inc. Impairment of Intangible Assets (Excluding Goodwill)
Onconetix, Inc. (ONCO) reported Impairment of Intangible Assets (Excluding Goodwill) of $0 for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2026-03-13
- Onconetix, Inc. impairment of intangible assets (excluding goodwill) for the quarter ending 2024-06-30 was $1.20M.
- Onconetix, Inc. impairment of intangible assets (excluding goodwill) for the quarter ending 2024-03-31 was $2.30M.
- Onconetix, Inc. impairment of intangible assets (excluding goodwill) for fiscal 2024 was $10.28M, a 30.01% decline from fiscal 2023.
- Onconetix, Inc. impairment of intangible assets (excluding goodwill) for fiscal 2023 was $14.69M.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 6 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | |||
| 2024-12-31 | $10.28M 10-K · filed 2026-03-13 | |||
| 2024-06-30 | $1.20M 10-Q · filed 2025-08-14 | $3.50M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $2.30M 10-Q · filed 2025-06-12 | |||
| 2023-12-31 | $14.69M 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |